The chitinase 3-like 1 gene and schizophrenia: Evidence from a multi-center case-control study and meta-analysis

Schizophrenia Research

Volumn 116, Issue 2-3, 2010, Pages 126-132

  Ohi, Kazutaka ^a,b   Hashimoto, Ryota ^a,b   Yasuda, Yuka ^a,b   Yoshida, Tetsuhiko ^a,b   Takahashi, Hidetoshi ^a,b   Iike, Naomi ^a,b   Iwase, Masao ^a   Kamino, Kouzin ^a,c   Ishii, Ryouhei ^a   Kazui, Hiroaki ^a   Fukumoto, Motoyuki ^a,b   Takamura, Hironori ^a,b   Yamamori, Hidenaga ^a   Azechi, Michiyo ^a   Ikezawa, Koji ^a   Tanimukai, Hitoshi ^a   Tagami, Shinji ^a   Morihara, Takashi ^a   Okochi, Masayasu ^a   Yamada, Kazuo ^d   Numata, Shusuke ^e   Ikeda, Masashi ^b,f   Tanaka, Toshihisa ^a   Kudo, Takashi ^a   Ueno, Shu ichi ^g   Yoshikawa, Takeo ^d   Ohmori, Tetsuro ^e   Iwata, Nakao ^b,f   Ozaki, Norio ^b,h   Takeda, Masatoshi ^a   more..

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c Shoraiso National Hospital   (Japan)

^d RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^e UNIVERSITY OF TOKUSHIMA   (Japan)

^f FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Association study; Chitinase 3 like 1 (CHI3L1) gene; Meta analysis; Schizophrenia; Single nucleotide polymorphism (SNP); YKL 40

Indexed keywords

CHITINASE; CHITINASE 3 LIKE 1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CHINESE; DISEASE PREDISPOSITION; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE MAP; HUMAN; JAPANESE; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CROSS-CULTURAL COMPARISON; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GLYCOPROTEINS; HUMANS; LECTINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; YOUNG ADULT;

EID: 74849098503     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.12.002     Document Type: Article

References (44)

1. Arion D., Unger T., Lewis D.A., Levitt P., and Mirnics K. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol. Psychiatry 62 (2007) 711-721
2. Bakkenist C.J., and Kastan M.B. Initiating cellular stress responses. Cell 118 (2004) 9-17
3. Bergmann O.J., Johansen J.S., Klausen T.W., Mylin A.K., Kristensen J.S., Kjeldsen E., and Johnsen H.E. High serum concentration of YKL-40 is associated with short survival in patients with acute myeloid leukemia. Clin. Cancer Res. 11 (2005) 8644-8652
4. Betcheva E.T., Mushiroda T., Takahashi A., Kubo M., Karachanak S.K., Zaharieva I.T., Vazharova R.V., Dimova I.I., Milanova V.K., Tolev T., Kirov G., Owen M.J., O'Donovan M.C., Kamatani N., Nakamura Y., and Toncheva D.I. Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. J. Hum. Genet. 54 (2009) 98-107
5. Cardno A.G., and Gottesman I.I. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am. J. Med. Genet. 97 (2000) 12-17
6. Chung C., Tallerico T., and Seeman P. Schizophrenia hippocampus has elevated expression of chondrex glycoprotein gene. Synapse 50 (2003) 29-34
7. Hashimoto R., Numakawa T., Ohnishi T., Kumamaru E., Yagasaki Y., Ishimoto T., Mori T., Nemoto K., Adachi N., Izumi A., Chiba S., Noguchi H., Suzuki T., Iwata N., Ozaki N., Taguchi T., Kamiya A., Kosuga A., Tatsumi M., Kamijima K., Weinberger D.R., Sawa A., and Kunugi H. Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum. Mol. Genet. 15 (2006) 3024-3033
8. Hashimoto R., Hashimoto H., Shintani N., Chiba S., Hattori S., Okada T., Nakajima M., Tanaka K., Kawagishi N., Nemoto K., Mori T., Ohnishi T., Noguchi H., Hori H., Suzuki T., Iwata N., Ozaki N., Nakabayashi T., Saitoh O., Kosuga A., Tatsumi M., Kamijima K., Weinberger D.R., Kunugi H., and Baba A. Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. Mol. Psychiatry 12 (2007) 1026-1032
9. Howes O.D., McDonald C., Cannon M., Arseneault L., Boydell J., and Murray R.M. Pathways to schizophrenia: the impact of environmental factors. Int. J. Neuropsychopharmacol. 7 Suppl 1 (2004) S7-S13
10. Jang Y.L., Kim J.W., Lee Y.S., Park D.Y., Cho E.Y., Jeun H.O., Lee D., and Hong K.S. Linkage of schizophrenia with chromosome 1q32 in Korean multiplex families. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B (2007) 279-284
11. Johansen J.S. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan. Med. Bull. 53 (2006) 172-209
12. Johansen J.S., Williamson M.K., Rice J.S., and Price P.A. Identification of proteins secreted by human osteoblastic cells in culture. J. Bone Miner. Res. 7 (1992) 501-512
13. Johansen J.S., Jensen B.V., Roslind A., Nielsen D., and Price P.A. Serum YKL-40, a new prognostic biomarker in cancer patients?. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 194-202
14. Junker N., Johansen J.S., Hansen L.T., Lund E.L., and Kristjansen P.E. Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells. Cancer Sci. 96 (2005) 183-190
15. Kirkpatrick R.B., Matico R.E., McNulty D.E., Strickler J.E., and Rosenberg M. An abundantly secreted glycoprotein from Drosophila melanogaster is related to mammalian secretory proteins produced in rheumatoid tissues and by activated macrophages. Gene 153 (1995) 147-154
16. Kruit A., Grutters J.C., Ruven H.J., van Moorsel C.C., and van den Bosch J.M. A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker. Respir. Med. 101 (2007) 1563-1571
17. Kucur M., Isman F.K., Karadag B., Vural V.A., and Tavsanoglu S. Serum YKL-40 levels in patients with coronary artery disease. Coron. Artery Dis. 18 (2007) 391-396
18. Leff J. Stress reduction in the social environment of schizophrenic patients. Acta Psychiatr. Scand. Suppl. 384 (1994) 133-139
19. Ling H., and Recklies A.D. The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha. Biochem. J. 380 (2004) 651-659
20. Mittal V.A., Ellman L.M., and Cannon T.D. Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications. Schizophr. Bull. 34 (2008) 1083-1094
21. Nicodemus K.K. Catmap: case-control and TDT meta-analysis package. BMC Bioinformatics 9 (2008) 130
22. Nojgaard C., Host N.B., Christensen I.J., Poulsen S.H., Egstrup K., Price P.A., and Johansen J.S. Serum levels of YKL-40 increases in patients with acute myocardial infarction. Coron. Artery Dis. 19 (2008) 257-263
23. Nordenbaek C., Johansen J.S., Halberg P., Wiik A., Garbarsch C., Ullman S., Price P.A., and Jacobsen S. High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement. Scand. J. Rheumatol. 34 (2005) 293-297
24. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet. 74 (2004) 765-769
25. Ober C., Tan Z., Sun Y., Possick J.D., Pan L., Nicolae R., Radford S., Parry R.R., Heinzmann A., Deichmann K.A., Lester L.A., Gern J.E., Lemanske Jr. R.F., Nicolae D.L., Elias J.A., and Chupp G.L. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N. Engl. J. Med. 358 (2008) 1682-1691
26. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., Dwyer S., Holmans P., Marchini J.L., Spencer C.C., Howie B., Leung H.T., Hartmann A.M., Moller H.J., Morris D.W., Shi Y., Feng G., Hoffmann P., Propping P., Vasilescu C., Maier W., Rietschel M., Zammit S., Schumacher J., Quinn E.M., Schulze T.G., Williams N.M., Giegling I., Iwata N., Ikeda M., Darvasi A., Shifman S., He L., Duan J., Sanders A.R., Levinson D.F., Gejman P.V., Cichon S., Nothen M.M., Gill M., Corvin A., Rujescu D., Kirov G., Owen M.J., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., and Cloninger C.R. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 40 (2008) 1053-1055
27. Ohi K., Hashimoto R., Yasuda Y., Yoshida T., Takahashi H., Iike N., Fukumoto M., Takamura H., Iwase M., Kamino K., Ishii R., Kazui H., Sekiyama R., Kitamura Y., Azechi M., Ikezawa K., Kurimoto R., Kamagata E., Tanimukai H., Tagami S., Morihara T., Ogasawara M., Okochi M., Tokunaga H., Numata S., Ikeda M., Ohnuma T., Ueno S., Fukunaga T., Tanaka T., Kudo T., Arai H., Ohmori T., Iwata N., Ozaki N., and Takeda M. Association study of the G72 gene with schizophrenia in a Japanese population: a multicenter study. Schizophr. Res. 109 (2009) 80-85
28. Ostergaard C., Johansen J.S., Benfield T., Price P.A., and Lundgren J.D. YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis. Clin. Diagn. Lab. Immunol. 9 (2002) 598-604
29. Palomo T., Archer T., Kostrzewa R.M., and Beninger R.J. Gene-environment interplay in schizopsychotic disorders. Neurotox. Res. 6 (2004) 1-9
30. Potvin S., Stip E., Sepehry A.A., Gendron A., Bah R., and Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol. Psychiatry 63 (2008) 801-808
31. Recklies A.D., White C., and Ling H. The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem. J. 365 (2002) 119-126
32. Recklies A.D., Ling H., White C., and Bernier S.M. Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes. J. Biol. Chem. 280 (2005) 41,213-41,221
33. Rehli M., Krause S.W., and Andreesen R. Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics 43 (1997) 221-225
34. Shaw S.H., Kelly M., Smith A.B., Shields G., Hopkins P.J., Loftus J., Laval S.H., Vita A., De Hert M., Cardon L.R., Crow T.J., Sherrington R., and DeLisi L.E. A genome-wide search for schizophrenia susceptibility genes. Am. J. Med. Genet. 81 (1998) 364-376
35. Skol A.D., Scott L.J., Abecasis G.R., and Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet. 38 (2006) 209-213
36. Sun J., Kuo P.H., Riley B.P., Kendler K.S., and Zhao Z. Candidate genes for schizophrenia: a survey of association studies and gene ranking. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B (2008) 1173-1181
37. Trikha M., Corringham R., Klein B., and Rossi J.F. Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. Clin. Cancer Res. 9 (2003) 4653-4665
38. Tsuji T., Matsuyama Y., Natsume N., Hasegawa Y., Kondo S., Kawakami H., Yoshihara H., and Iwata H. Analysis of chondrex (YKL-40, HC gp-39) in the cerebrospinal fluid of patients with spine disease. Spine 27 (2002) 732-735
39. Vind I., Johansen J.S., Price P.A., and Munkholm P. Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease. Scand. J. Gastroenterol. 38 (2003) 599-605
40. Volck B., Price P.A., Johansen J.S., Sorensen O., Benfield T.L., Nielsen H.J., Calafat J., and Borregaard N. YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc. Assoc. Am. Physicians 110 (1998) 351-360
41. Yamada K., Hattori E., Iwayama Y., Toyota T., Ohnishi T., Iwata Y., Tsuchiya K.J., Sugihara G., Kikuchi M., Okazaki Y., and Yoshikawa T. Failure to confirm genetic association of the CHI3L1 gene with schizophrenia in Japanese and Chinese populations. Am. J. Med. Genet. B Neuropsychiatr. Genet 150B (2008) 508-514
42. Yamaguchi-Kabata Y., Nakazono K., Takahashi A., Saito S., Hosono N., Kubo M., Nakamura Y., and Kamatani N. Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am. J. Hum. Genet. 83 (2008) 445-456
43. Yang M.S., Morris D.W., Donohoe G., Kenny E., O'Dushalaine C.T., Schwaiger S., Nangle J.M., Clarke S., Scully P., Quinn J., Meagher D., Baldwin P., Crumlish N., O'Callaghan E., Waddington J.L., Gill M., and Corvin A. Chitinase-3-like 1 (CHI3L1) gene and schizophrenia: genetic association and a potential functional mechanism. Biol. Psychiatry 64 (2008) 98-103
44. Zhao X., Tang R., Gao B., Shi Y., Zhou J., Guo S., Zhang J., Wang Y., Tang W., Meng J., Li S., Wang H., Ma G., Lin C., Xiao Y., Feng G., Lin Z., Zhu S., Xing Y., Sang H., St Clair D., and He L. Functional variants in the promoter region of chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia. Am. J. Hum. Genet. 80 (2007) 12-18